F2 and primary biliary cholangitis: Similarly, a clinical trial showed that the UDCA and bezafibrate combination was, by far, more efficient than UDCA alone in achieving a complete biochemical response as defined by surrogate markers including bilirubin, ALP, albumin, and prothrombin index time (PT) in PBC patients [43].